NLRC5 promotes endometrial carcinoma progression by regulating NF-κB pathway-mediated mismatch repair gene deficiency

Xiaojing Liu,Haiqing Zhu,Bao Guo,Jiahua Chen,Junhui Zhang,Tao Wang,Jing Zhang,Wenjun Shan,Junchi Zou,Yunxia Cao,Bing Wei,Lei Zhan

DOI: https://doi.org/10.1038/s41598-024-63457-2

IF: 4.6

2024-06-01

Scientific Reports

Abstract:The innate immune molecule NLR family CARD domain-containing 5 (NLRC5) plays a significant role in endometrial carcinoma (EC) immunosurveillance. However, NLRC5 also plays a protumor role in EC cells. Mismatch repair gene deficiency (dMMR) can enable tumors to grow faster and also can exhibit high sensitivity to immune checkpoint inhibitors. In this study, we attempted to determine whether NLRC5-mediated protumor role in EC is via the regulation of dMMR. Our findings revealed that NLRC5 promoted the proliferation, migration, and invasion abilities of EC cells and induced the dMMR status of EC in vivo and in vitro. Furthermore, the mechanism underlying NLRC5 regulated dMMR was also verified. We first found NLRC5 could suppress nuclear factor-kappaB (NF-κB) pathway in EC cells. Then we validated that the positive effect of NLRC5 in dMMR was restricted when NF-κB was activated by lipopolysaccharides in NLRC5-overexpression EC cell lines. In conclusion, our present study confirmed the novel NLRC5/NF-κB/MMR regulatory mechanism of the protumor effect of NLRC5 on EC cells, thereby suggesting that the NLRC5-mediated protumor in EC was depend on the function of MMR.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the specific mechanism by which NLR family CARD - domain - containing protein 5 (NLRC5) exerts a tumor - promoting role in endometrial cancer (EC) by regulating mismatch repair gene deficiency (dMMR). Specifically, the study aims to verify whether NLRC5 induces dMMR by inhibiting the nuclear factor - κB (NF - κB) pathway, thereby promoting the proliferation, migration and invasion abilities of EC cells. In addition, the study also attempts to reveal whether the tumor - promoting role of NLRC5 in EC depends on its inhibition of the NF - κB pathway.

### Research Background
1. **Endometrial Cancer (EC)**: EC is the sixth most common cancer in women and usually occurs in elderly women. In recent years, with the increase in the incidence of EC and the younger age of onset, the treatment of EC has attracted more and more attention. Surgery, radiotherapy and chemotherapy are the main treatment methods, but they are not effective for high - grade and recurrent diseases.
2. **Mismatch Repair Gene Deficiency (dMMR)**: According to the mutation load and somatic copy number variation, TCGA divides EC into four different molecular subgroups, one of which is dMMR or high - mutation microsatellite instability (MSI - H). dMMR tumors account for 17% - 33% of all EC. dMMR leads to genomic instability and accelerates tumorigenesis and development.
3. **The Role of NLRC5**: NLRC5 plays an important role in immune and inflammatory responses, but it shows different roles in different cancers. In some cancers, NLRC5 inhibits tumor progression, while in other cancers it promotes tumor progression. Therefore, the specific role of NLRC5 in EC is still unclear.

### Research Objectives
1. **Verify the Tumor - promoting Role of NLRC5 in EC**: The study verified the tumor - promoting role of NLRC5 in EC cells through in vitro and in vivo experiments, including promoting cell proliferation, migration and invasion.
2. **Explore the Mechanism by which NLRC5 Induces dMMR**: The study found that NLRC5 induces dMMR by inhibiting the NF - κB pathway, thereby promoting the proliferation, migration and invasion of EC cells.
3. **Evaluate Whether the Tumor - promoting Role of NLRC5 Depends on the NF - κB Pathway**: By activating the NF - κB pathway (using lipopolysaccharide LPS), the study further confirmed that the tumor - promoting role of NLRC5 does indeed depend on its inhibition of the NF - κB pathway.

### Main Conclusions
1. **NLRC5 Promotes the Proliferation, Migration and Invasion of EC Cells**: In vitro and in vivo experiments have confirmed that NLRC5 overexpression significantly promotes the proliferation, migration and invasion abilities of EC cells.
2. **NLRC5 Induces dMMR by Inhibiting the NF - κB Pathway**: NLRC5 overexpression inhibits the activation of the NF - κB pathway, resulting in the appearance of the dMMR state.
3. **The Tumor - promoting Role of NLRC5 Depends on the Inhibition of the NF - κB Pathway**: Activating the NF - κB pathway can reverse the tumor - promoting effect of NLRC5, indicating that the tumor - promoting role of NLRC5 does indeed depend on its inhibition of the NF - κB pathway.

These findings not only reveal the tumor - promoting mechanism of NLRC5 in EC, but also provide a theoretical basis for the development of precise treatment strategies targeting NLRC5.